Xcout IntelSign inSubscribe

Syngene International

SYNGENEBiotechIndia

Syngene International is a contract research, development, and manufacturing organization (CRDMO) that provides integrated discovery, development, and manufacturing services for small molecules, biologics, and other therapeutic modalities. It serves clients in the pharmaceutical, biotechnology, nutrition, animal health, and agrochemical industries by supporting their research and commercial production needs.

Subscribe to see Syngene International’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Syngene International at a glance

Syngene International is a biotech company headquartered in India, founded in 1994. Xcout tracks 7 named people at Syngene International, including Siddharth Mittal (Managing Director and CEO).

Industry
Biotech
Headquarters
India
Ticker
SYNGENE
Founded
1994

Syngene International leadership

  • Siddharth MittalManaging Director and CEO
  • Kiran Mazumdar-ShawExecutive Chairperson
  • Manja BoermanIndependent Director
  • Nilanjan RoyIndependent Director
  • Professor Catherine RosenbergNon-Executive Director
  • Sharmila KarveLead Independent Director

1 more named person on record for Syngene International, with roles, board committees and tenure — see the full roster →

Syngene International competitors

A few of Syngene International's closest competitors — see the full list of competitors and alternatives →

Anthem Biosciences LimitedANTHEM · BiotechBengaluru, India
71% matchPublic

Anthem Biosciences Ltd. operates as a technology-driven organization specializing in contract research, development, and manufacturing (CRDMO). The company's activities are organized into two primary divisions: CRDMO services and the production of Specialty Ingredients. Through its CRDMO segment, Anthem Biosciences offers comprehensive, full-lifecycle support for both novel chemical and biological entities. This support spans the entire development pipeline, from initial target identification and concept generation, through preclinical evaluation, the creation of development batches for all three phases of clinical trials, and ultimately, commercial-scale manufacturing. Their expertise covers a wide array of advanced therapeutic areas, including RNA-based therapies, antibody-drug conjugates, peptides, oligonucleotides, lipids, biologics, and biotherapeutics. They also employ specialized processes such as fermentation, biosynthesis, biotransformation, and flow chemistry. In its Specialty Ingredients division, Anthem Biosciences manufactures and supplies intricate, fermentation-derived active pharmaceutical ingredients (APIs), including serratiopeptidase protease and vitamin K2. The company's portfolio also encompasses microbial and mammalian biosimilars, a diverse range of probiotics (such as various species of bacillus, lactobacillus, bifidobacterium, streptococcus, and saccharomyces boulardii), and enzymes. Additionally, they produce key peptides like semaglutide, plecanatide, linaclotide, liraglutide, and cilengitide, alongside nutritional actives, vitamin analogues, and other APIs. The company was established in Bengaluru, India, in 2006.

Market cap$5.3B
Employees2,062
Anthem Biosciences Limited competitors & alternatives →

Get Syngene International's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Syngene International — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Syngene International in Xcout Intel

  • 7 named people with titles, LinkedIn and board committees
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →